Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Serum soluble CD23 level correlates with subsequent development of AIDS-related non-Hodgkin's lymphoma.

Schroeder JR, Saah AJ, Hoover DR, Margolick JB, Ambinder RF, Martinez-Maza O, Breen EC, Jacobson LP, Variakojis D, Rowe DT, Armenian HK.

Cancer Epidemiol Biomarkers Prev. 1999 Nov;8(11):979-84.

2.

Serum sCD23 level in patients with AIDS-related non-Hodgkin's lymphoma is associated with absence of Epstein-Barr virus in tumor tissue.

Schroeder JR, Saah AJ, Ambinder RF, Martinez-Maza O, Crabb Breen E, Variakojis D, Margolick JB, Jacobson LP, Rowe DT, Hoover DR.

Clin Immunol. 1999 Dec;93(3):239-44.

PMID:
10600334
3.
4.

Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain.

Bossolasco S, Nilsson A, de Milito A, Lazzarin A, Linde A, Cinque P, Chiodi F.

AIDS. 2001 Jun 15;15(9):1109-13.

PMID:
11416712
5.

Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin's lymphoma.

Zinzani PL, Baccini C, Zaccaria A, Visani G, Buzzi M, Morelli A, Molinari AL, Salvucci M, Bendandi M, Rubboli D, Gherlinzoni F, Zanchini R, Tura S.

Eur J Haematol. 1996 Nov;57(5):335-40.

PMID:
9003473
6.

The development of AIDS-associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6.

Breen EC, van der Meijden M, Cumberland W, Kishimoto T, Detels R, Martínez-Maza O.

Clin Immunol. 1999 Sep;92(3):293-9.

PMID:
10479534
7.

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM.

AIDS. 2000 Jan 28;14(2):133-40.

PMID:
10708283
9.

High serum hepatocyte growth factor level in patients with non-Hodgkin's lymphoma.

Hsiao LT, Lin JT, Yu IT, Chiou TJ, Liu JH, Yen CC, Wang WS, Chen PM.

Eur J Haematol. 2003 May;70(5):282-9.

PMID:
12694163
10.

Elevated serum level of soluble CD23 precedes development of B-non-Hodgkin's lymphoma in SIV-infected Rhesus monkeys.

Hannig H, Buske C, Mätz-Rensing K, Hunsmann G, Hiddemann W, Bodemer W.

Int J Cancer. 1998 Aug 31;77(5):734-40.

11.
12.

[Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].

Corti M, Villafañe Fioti MF, Lewi D, Schtirbu R, Narbaitz M, de Dios Soler M.

Acta Gastroenterol Latinoam. 2006 Dec;36(4):190-6. Spanish.

PMID:
17225446
13.

Risk factors for non-Hodgkin's lymphomas in acquired immunodeficiency syndrome (AIDS)

Armenian HK, Hoover DR, Rubb S, Metz S, Martinez-Maza O, Chmiel J, Kingsley L, Saah A.

Am J Epidemiol. 1996 Feb 15;143(4):374-9.

PMID:
8633621
14.

[Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].

Jacomet C, Lesens O, Villemagne B, Darcha C, Tournilhac O, Henquell C, Cormerais L, Gourdon F, Peigue-Lafeuille H, Travade P, Beytout J, Laurichesse H.

Med Mal Infect. 2006 Mar;36(3):157-62. Epub 2006 Feb 28. French.

PMID:
16503104
15.

Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment.

Altun B, Erdem Y, Usalan C, Arici M, Haznedaroglu IC, Yasavul U, Turgan C, Caglar S, Kirazli S.

Clin Nephrol. 1999 Oct;52(4):230-8.

PMID:
10543325
16.

B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.

Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, Kaslow RA, Variakojis D, Bream JH, Rinaldo CR, Ambinder RF, Martinez-Maza O.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1303-14. doi: 10.1158/1055-9965.EPI-11-0037. Epub 2011 Apr 28.

17.

Soluble CD23 in allergic diseases.

Rogala B, Rymarczyk B.

Arch Immunol Ther Exp (Warsz). 1999;47(4):251-5.

PMID:
10483874
18.

Serum levels of soluble CD23 in patients with bullous pemphigoid.

Maekawa N, Hosokawa H, Soh H, Kasahara M, Izumi H, Yodoi J, Asada Y.

J Dermatol. 1995 May;22(5):310-5.

PMID:
7673549
19.

CD23 antigen expression on B lymphocytes and soluble CD23 levels in peripheral blood of high-risk type 1 diabetes subjects.

Kretowski A, Szelachowska M, Pietruczuk M, Kinalska I.

Scand J Immunol. 1999 Jan;49(1):78-81.

20.

Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.

Molica S, Levato D, Dell'Olio M, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P.

Haematologica. 1996 Sep-Oct;81(5):428-33.

Supplemental Content

Support Center